Further large-scale studies are warranted to confirm the results of our study, determine the accuracy of ApoB/ApoA1 ratio for the diagnosis of MS, and clarify the role of gender, smoking, and dietary habits. This evidence concerns the gene APOB and myeloid sarcoma.